On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Liver Disease and Transplantation

TopicLeading institutions, researchers & key papers

Liver Disease and Transplantation is a topic indexed in ScholarIQ from OpenAlex.

What is known about Liver Disease and Transplantation?

ScholarIQrecord summary

This cluster of papers focuses on the management, prognosis, and complications of liver cirrhosis, including topics such as hepatic encephalopathy, portal hypertension, ascites, hepatorenal syndrome, variceal hemorrhage, MELD score, transjugular intrahepatic portosystemic shunt (TIPS), acute-on-chronic liver failure, and coagulopathy.

How many works does Liver Disease and Transplantation have?

ScholarIQindexed works

Liver Disease and Transplantation has 728 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Liver Disease and Transplantation?

ScholarIQopenalex

The OpenAlex for Liver Disease and Transplantation is on the source record.

What are the most-cited papers on Liver Disease and Transplantation?

ScholarIQmost cited works
A Model to Predict Survival in Patients With End–Stage Liver Disease
Patrick S. Kamath, Russell H. Wiesner, Michael Malinchoc, Walter K. Kremers, Terry M. Therneau, Catherine L. Kosberg, Gennaro D’Amico, Rolland E. Dickson, Ray W. Kim
Hepatology. 20014,960 Citations
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
Richard Moreau, Rajiv Jalan, Pere Ginès, Marco Pavesi, Paolo Angeli, Juan Córdoba, François Durand, Thierry Gustot, Faouzi Saliba, Marco Domenicali, Alexander Gerbes, Julia Wendon, Carlo Alessandria, Wim Laleman, Stefan Zeuzem, Jonel Trebicka, Mauro Bernardi, Vicente Arroyo
Gastroenterology. 20133,013 Citations
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Paolo Angeli, Mauro Bernardi, Càndid Villanueva, Claire Francoz, Rajeshwar P. Mookerjee, Jonel Trebicka, Aleksander Krag, Wim Laleman, Pere Ginès
Journal of Hepatology. 20182,878 CitationsOPEN ACCESS
Baveno VII – Renewing consensus in portal hypertension
Roberto de Franchis, Jaime Bosch, Guadalupe García–Tsao, Thomas Reiberger, Cristina Ripoll, Juan G. Abraldeṣ, Agustı́n Albillos, Anna Baiges, Jasmohan S. Bajaj, Rafael Bañares, Marta Barrufet, Lina Benajiba, Annalisa Berzigotti, Christophe Bureau, Vincenza Calvaruso, Andrés Cárdenas, Gennaro D’Amico, Andrea De Gottardi, Alessandra Dell’Era, Àngels Escorsell, Jonathan Fallowfield, Héctor Ferral, Sven Francque, Ron C. Gaba, Juan Carlos García‐Pagán, Joan Genescà, Susana Rodrigues, Jordi Gracia‐Sancho, Guogong Han, Virginia Hernández–Gea, Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji
Journal of Hepatology. 20212,764 CitationsOPEN ACCESS
Model for end-stage liver disease (MELD) and allocation of donor livers
Russell H. Wiesner, Erick Edwards, Richard B. Freeman, Ann Harper, Ray Kim, Patrick S. Kamath, Walter K. Kremers, John R. Lake, Todd K. Howard, Robert M. Merion, Robert A. Wolfe, Ruud A. F. Krom
Gastroenterology. 20032,540 CitationsOPEN ACCESS

Where is Liver Disease and Transplantation research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Liver Disease and Transplantation is open access?

ScholarIQopen access share
73%OPEN ACCESS
Gold
0%
Green
7%
Hybrid
13%
Bronze
53%
Closed
27%

Related on ScholarIQ

470M+ articles · 14-day free trial